cash on hand

Hi,

I was perusing the annual report and saw that cash in the bank was enough for the rest of the financial year and maybe longer with the recently received grant based on their cash burn last quarter. There are some dollars to be made from the options but I can't remember whether they expired 2005 or 2006.

Can anyone tell me whether they think the company is gonna be cash flow positive before they need to raise money. Obviously a commercial deal will help but are their products that far advanced to be sold in the market place.

Just trying to learn a bit more about the process of biotech stocks and getting a product to market. If anyone knows any good artices about the process I am more than willing to read.

Cheers,

Nifty

PS I hold a few